4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0000899243-22-037480
10% owner sold 212,329 shares at an average $27.77 ($5,895,941)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SVF Endurance (Cayman) Ltd 10% owner | 2022-11-30 | Sale | −102,291 | $27.65 | $2,828,019 | 20,908,866 | I: show line 1 in the form |
| SVF Endurance (Cayman) Ltd 10% owner | 2022-11-30 | Sale | −63,662 | $28.17 | $1,793,588 | 20,845,204 | I: show line 2 in the form |
| SVF Endurance (Cayman) Ltd 10% owner | 2022-12-01 | Sale | −40,276 | $27.39 | $1,103,031 | 20,804,928 | I: show line 3 in the form |
| SVF Endurance (Cayman) Ltd 10% owner | 2022-12-01 | Sale | −6,100 | $28.08 | $171,303 | 20,798,828 | I: show line 4 in the form |
| Open-market sales · 212,329 sh · avg $27.77 · $5,895,941 | |||||||
Loading xslF345X03/doc4.xml…